Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.

Ingavirin (imidazolyl ethanamide pentandioic acid) - Myelo Therap, Valenta Pharm

Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections. (clinicaltrials.gov) - Feb 20, 2026 - P2 | N=300 | Recruiting | Sponsor: Valenta Pharm JSC
New P2 trial • Infectious Disease • Influenza • Respiratory Diseases

http://clinicaltrials.gov/ct2/show/NCT07420985

Feb 20, 2026